Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Welcure Drugs & Pharmaceuticals's quarterly market cap
declined
from Sep. 2025 (₹618 Mil) to Dec. 2025 (₹519 Mil) and
declined
from Dec. 2025 (₹519 Mil) to Mar. 2026 (₹297 Mil).
Welcure Drugs & Pharmaceuticals's annual market cap
increased
from Mar. 2024 (₹51 Mil) to Mar. 2025 (₹1,023 Mil) but then
declined
from Mar. 2025 (₹1,023 Mil) to Mar. 2026 (₹297 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Welcure Drugs & Pharmaceuticals's Enterprise Value for Today is ₹291 Mil.
Welcure Drugs & Pharmaceuticals (BOM:524661) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Welcure Drugs & Pharmaceuticals Market Cap Related Terms
Welcure Drugs & Pharmaceuticals Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524661 vs MCK, COR, CAH: Market Cap Comparison
For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcure Drugs & Pharmaceuticals Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Welcure Drugs & Pharmaceuticals's Market Cap falls into.
Welcure Drugs & Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Market Cap of ₹297 Mil as of Jul. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. According to the industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #112 out of 122 companies in the Medical Distribution industry, placing it in the top 91.8%.
Is Welcure Drugs & Pharmaceuticals' Market Cap too high?
Welcure Drugs & Pharmaceuticals' current Market Cap is ₹297 Mil. Based on the distribution chart, Welcure Drugs & Pharmaceuticals ranks #112 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #112 out of 122 companies for Market Cap. This places Welcure Drugs & Pharmaceuticals in the lower half of its industry. The industry median Market Cap is 134.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 134.57, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Market Cap is 134.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcure Drugs & Pharmaceuticals's current Market Cap is ₹297 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Market Cap of ₹297 Mil. The current Market Cap is ₹297 Mil. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Market Cap is ₹297 Mil as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Welcure Drugs & Pharmaceuticals Business Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score
Get the complete analysis for BOM:524661
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524661 has been successfully added to your 
